MX2015003262A - Composicion farmaceutica topica. - Google Patents
Composicion farmaceutica topica.Info
- Publication number
- MX2015003262A MX2015003262A MX2015003262A MX2015003262A MX2015003262A MX 2015003262 A MX2015003262 A MX 2015003262A MX 2015003262 A MX2015003262 A MX 2015003262A MX 2015003262 A MX2015003262 A MX 2015003262A MX 2015003262 A MX2015003262 A MX 2015003262A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- optonally
- ciclopirox
- tenofovir
- topical pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere en general a una composición farmacéutica tópica que comprende un agente antirretroviral en combinación con un agente bactericida y, opcionalmente, un agente antifúngico, en particular para uso como anticonceptivo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2687MU2012 | 2012-09-14 | ||
PCT/GB2013/053001 WO2014041378A2 (en) | 2012-09-14 | 2013-11-14 | Topical pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015003262A true MX2015003262A (es) | 2016-06-10 |
Family
ID=49725153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015003262A MX2015003262A (es) | 2012-09-14 | 2013-11-14 | Composicion farmaceutica topica. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20150246065A1 (es) |
EP (1) | EP2968109A2 (es) |
JP (1) | JP2015528490A (es) |
AU (1) | AU2013316819A1 (es) |
BR (1) | BR112015005633A2 (es) |
CA (1) | CA2885037A1 (es) |
MX (1) | MX2015003262A (es) |
RU (1) | RU2015110470A (es) |
WO (1) | WO2014041378A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110229565A1 (en) | 2008-09-17 | 2011-09-22 | Karp Jeffrey M | Drug Delivery Composition Comprising a Self-Assembled Gelator |
WO2012040623A2 (en) | 2010-09-24 | 2012-03-29 | The Brigham And Women's Hospital, Inc. | Nanostructured gels capable of controlled release of encapsulated agents |
BR112014030984B1 (pt) | 2012-06-13 | 2022-05-24 | Evofem, Inc | Composições e métodos para aumentar a eficácia de microbicidas contraceptivos |
KR101669240B1 (ko) * | 2015-03-12 | 2016-10-25 | 아주대학교산학협력단 | 테노포비어 디소프록실 유리염기를 포함하는 정제 및 이의 제조방법 |
KR20170003063A (ko) * | 2015-06-30 | 2017-01-09 | 한미약품 주식회사 | 테노포비어 디소프록실 함유 경구용 고형제제 및 그 제조방법 |
WO2018067568A1 (en) * | 2016-10-04 | 2018-04-12 | Evofem Biosciences, Inc. | Method of treatment and prevention of bacterial vaginosis |
US11020410B2 (en) | 2017-02-03 | 2021-06-01 | The Brigham And Women's Hospital, Inc. | Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof |
AU2018266131B2 (en) | 2017-05-08 | 2021-07-29 | Alivio Therapeutics, Inc. | Formulation of nanostructured gels for increased agent loading and adhesion |
US10688043B1 (en) | 2018-03-20 | 2020-06-23 | Mario Elmen Tremblay | Personal lubricants comprising lambda-carrageenan |
US12043598B2 (en) | 2018-03-20 | 2024-07-23 | Lanvira, Llc | Condoms lubricated with antiviral lubricious compositions containing lambda-carrageenan |
US11744796B2 (en) * | 2018-03-20 | 2023-09-05 | Alternative Packaging Solutions, Llc | Personal lubricants comprising lambda-carrageenan |
US12036313B2 (en) | 2018-03-20 | 2024-07-16 | Lanvira, Llc | Personal lubricants comprising lambda-carrageenan |
AU2019357859A1 (en) | 2018-10-11 | 2021-06-03 | Alivio Therapeutics, Inc. | Non-injectable hydrogel formulations for smart release |
WO2022076804A1 (en) * | 2020-10-08 | 2022-04-14 | North Carolina State University | Multifunctional contraceptive gel compositions and related methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2722689B1 (fr) | 1994-07-20 | 1996-10-04 | Fabre Pierre Dermo Cosmetique | Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant |
FR2740685B1 (fr) | 1995-11-08 | 1998-01-23 | Pf Medicament | Composition pharmaceutique topique moussante pour le traitement des dermatoses, induites par pityrosporum ovale |
AU4766297A (en) * | 1996-10-31 | 1998-05-22 | Notax Holding Gesellschaft M.B.H. | Use of polyethylene glycol-9 nonylphenyl ether |
ITMI20010913A1 (it) * | 2001-05-04 | 2002-11-04 | Univ Pavia | Composizioni a rilascio controllato di acido lattico a livello vaginale |
WO2004105662A1 (en) | 2003-05-23 | 2004-12-09 | Program For Appropriate Technology In Health | Microbicidal compositions and methods of use |
UA93354C2 (ru) * | 2004-07-09 | 2011-02-10 | Гилиад Сайенсиз, Инк. | Местный противовирусный препарат |
AU2009237478A1 (en) * | 2008-04-16 | 2009-10-22 | Cipla Limited | Topical combinations comprising an antimycotic agent and an antiviral agent |
-
2013
- 2013-11-14 MX MX2015003262A patent/MX2015003262A/es unknown
- 2013-11-14 BR BR112015005633A patent/BR112015005633A2/pt not_active IP Right Cessation
- 2013-11-14 US US14/427,906 patent/US20150246065A1/en not_active Abandoned
- 2013-11-14 EP EP13802088.8A patent/EP2968109A2/en not_active Withdrawn
- 2013-11-14 JP JP2015531651A patent/JP2015528490A/ja active Pending
- 2013-11-14 AU AU2013316819A patent/AU2013316819A1/en not_active Abandoned
- 2013-11-14 WO PCT/GB2013/053001 patent/WO2014041378A2/en active Application Filing
- 2013-11-14 RU RU2015110470A patent/RU2015110470A/ru not_active Application Discontinuation
- 2013-11-14 CA CA2885037A patent/CA2885037A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2014041378A2 (en) | 2014-03-20 |
EP2968109A2 (en) | 2016-01-20 |
AU2013316819A1 (en) | 2015-04-02 |
RU2015110470A (ru) | 2016-11-10 |
BR112015005633A2 (pt) | 2017-07-04 |
WO2014041378A3 (en) | 2014-05-30 |
JP2015528490A (ja) | 2015-09-28 |
CA2885037A1 (en) | 2014-03-20 |
US20150246065A1 (en) | 2015-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015003262A (es) | Composicion farmaceutica topica. | |
HRP20190164T1 (hr) | Paraziticidni oralni veterinarski sastavi koji obuhvaćaju djelatne tvari sa sustavnim djelovanjem, i načini njihove primjene | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
PH12014501671B1 (en) | Amidine substituted beta-lactam compounds, their preparation and use as antibacterial agents | |
IL235767A (en) | Preserved pyrolidines, pharmaceuticals containing them and their uses | |
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
IL235585B (en) | Substances that bind to ha, preparations containing them and their uses | |
GB201106750D0 (en) | Novel compounds | |
PH12015500900B1 (en) | A stabilized pemetrexed formulation | |
IL227705A (en) | Domestic antifungal material, preparations containing it and uses | |
EP2848122A4 (en) | NEW PESTICIDES INCLUSION COMPOUNDS, COMPOSITIONS WITH SAID COMPLEXES AND USE THEREOF AS PESTICIDES | |
EP3068436A4 (en) | Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine | |
ZA201505196B (en) | Topical ophthalmological pharmaceutical composition containing regorafenib | |
WO2014105777A8 (en) | Cobicostat dichlohydrate salt | |
MX345263B (es) | Formulación de pexiganan estable. | |
GB201304240D0 (en) | Metal complexes, compositions thereof and their uses | |
IN2013MU03582A (es) | ||
PL2852385T3 (pl) | Dronedaron do zastosowania w leiszmaniozie, formulacje i połączenia do stosowania w leiszmaniozie | |
WO2014020130A3 (en) | Albumin composition | |
IN2014MU01326A (es) | ||
AU2012904909A0 (en) | Dual action nitric oxide donors and their use as antimicrobial agents |